about
Parasitic Infections in Hematopoietic Stem Cell TransplantationNematode phospholipid metabolism: an example of closing the genome-structure-function circleMucosal leishmaniasis: an underestimated presentation of a neglected diseaseComputational studies on sirtuins from Trypanosoma cruzi: structures, conformations and interactions with phytochemicalsAntileishmanial activity of semisynthetic lupane triterpenoids betulin and betulinic acid derivatives: synergistic effects with miltefosineAn Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantiaArtemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling.The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivoAscaris lumbricoides β carbonic anhydrase: a potential target enzyme for treatment of ascariasis.Enteric protozoa in the developed world: a public health perspective.Immunomodulatory effects of antimicrobial agents. Part II: antiparasitic and antifungal agents.Understanding drug resistance in human intestinal protozoa.Enhanced photodynamic leishmanicidal activity of hydrophobic zinc phthalocyanine within archaeolipids containing liposomesStructural insights of SIR2rp3 proteins as promising biotargets to fight against Chagas disease and leishmaniasis.The Global State of Helminth Control and Elimination in Children.The morphological analysis of autophagy in primary skeletal muscle cells infected with Toxoplasma gondii.Enteric Parasitic Infections in Relation to Diarrhoea in HIV Infected Individuals with CD4 T Cell Counts <1000 Cells/μl in Chennai, IndiaParasitic infections in solid organ transplantation.Rapid resolution of toxoplasma chorioretinitis treatment using quadruple therapy.Delirium induced by albendazole-ivermectin combination: Report of the first case in an older patient.Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori.Treatment Options and Considerations for Intestinal Helminthic Infections.Synthesis and in vitro evaluation of leishmanicidal activity of 7-hydroxy-4-phenylcoumarin derivatives
P2860
Q26740380-41729253-AA58-420C-9D98-B02E7C7A251DQ26853143-88888FA4-924D-4387-ABDD-9F3CB4DD991BQ26998036-15AECCB8-D79E-41D4-BFAF-5AC065A9020BQ28539769-95AA12B5-F5CC-48AE-B418-0887E582CDA9Q28541041-41A41B7D-9141-417F-ADED-94B52552F0A4Q33630853-3A8F6C53-AA1D-4A21-AD36-ADCA6494F6C0Q34231069-6E5CD2EF-81BA-472D-99F5-619B037BCBADQ34289956-6FBF9EA5-3E8A-43F0-91AB-02DEC21715A8Q35781047-9608C9A1-B82F-4F31-BB79-325929C7D1B7Q36156094-D69CD5D9-079B-49DC-B005-5287B7EEDA22Q37991390-6F33D0F0-AE43-4AE3-8A98-43B292D96CABQ38381784-7539FDAA-244F-43BC-B745-ED236884109DQ38973386-C34572C7-060A-4797-A280-8359183D41DBQ39396789-6FAE5508-9E14-45F8-918E-79AEAC68CA1FQ39451885-09DE4263-3334-4E38-8740-084A70850529Q39853307-10E08B3E-A062-4F1B-97F1-E4C2343A7DF7Q42088202-AEFD8821-8EAC-4B1B-AD15-F6459E4B1C6CQ42272278-6471105F-BF6F-4067-B1D3-4694FD4BFDD9Q47125459-CB5230EC-E65D-4480-AA85-8419E6EC1FBCQ48370242-B881D23B-4220-4260-843F-548ACAE7CD75Q52688931-5D9E21D2-94C8-4EA3-AB4E-508463D7002FQ55243362-FBD84B76-656F-4C28-921F-AB1223BDD428Q57963728-7CEAC570-7595-46C5-B815-45E809C95728
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antiparasitic therapy
@ast
Antiparasitic therapy
@en
Antiparasitic therapy
@nl
type
label
Antiparasitic therapy
@ast
Antiparasitic therapy
@en
Antiparasitic therapy
@nl
prefLabel
Antiparasitic therapy
@ast
Antiparasitic therapy
@en
Antiparasitic therapy
@nl
P2093
P2860
P3181
P356
P1476
Antiparasitic therapy
@en
P2093
Brian G Blackburn
Shanthi Kappagoda
Upinder Singh
P2860
P304
P3181
P356
10.4065/MCP.2011.0203
P407
P577
2011-06-01T00:00:00Z